Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Percheron Therapeutics ( (AU:PER) ) has issued an update.
Percheron Therapeutics Limited has announced that Gregory Norman Peters and associated parties have ceased to be substantial holders in the company as of March 4, 2025. This change follows the consideration of resolutions proposed by these parties at a general meeting of shareholders, indicating a shift in the company’s shareholder structure and potentially impacting its governance and strategic direction.
More about Percheron Therapeutics
Average Trading Volume: 10,000
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $6.8M
See more data about PER stock on TipRanks’ Stock Analysis page.